What Happens If You Catch Hantavirus? Treatment Explained

Hantavirus has moved from a rare, regionally known infection to a globally watched public health concern practically overnight. In early May 2026, the World Health Organization was notified of a cluster of severe acute respiratory illness aboard the MV Hondius - a cruise ship sailing the Atlantic Ocean. The cause was the Andes strain of hantavirus - the only known hantavirus capable of spreading from person to person. At least three people have died. Eleven cases have been confirmed. Forty-one people across 16 U.S. states are under monitoring.

People everywhere are now asking the same question: what actually happens if you catch hantavirus?

The honest answer is this: there is no approved antiviral cure. No licensed vaccine exists. The disease can kill within 24 to 48 hours of its most severe phase. And yet, with aggressive early supportive care, many patients survive - and recover completely.

This article explains what hantavirus does to the body, stage by stage, and what modern medicine can and cannot do about it.

What Is Hantavirus - and Where Does It Come From?

Hantavirus is not a single virus. It is a family of over 50 RNA viruses naturally carried by rodents worldwide. In rodents, the infection persists without causing symptoms. In humans, it can be devastating.

Human infection typically occurs through:

• Inhalation of aerosolized particles from infected rodent urine, droppings, or saliva
• Direct contact with contaminated surfaces followed by touching the eyes, nose, or mouth
• Rodent bites in rare cases

The most dangerous exposure scenario is disturbing dried rodent droppings in enclosed, poorly ventilated spaces - old cabins, barns, garages, and storage rooms - where the virus becomes airborne. Many people who become infected report never having seen a rodent or its droppings at all.

The Andes Virus - The Human-to-Human Exception

Most hantavirus strains cannot pass between people. The Andes virus is the critical exception. According to the CDC, the Andes virus is the only type of hantavirus known to spread person-to-person - through close, prolonged contact with a symptomatic person, including exposure to saliva, respiratory secretions, or other body fluids.

The MV Hondius outbreak is the first documented case of Andes virus spreading in a cruise ship setting. It has alarmed public health officials not because the risk to the general public is high - the CDC and WHO both confirm overall risk remains extremely low - but because it represents an unusual and closely monitored transmission event.

Secondary infections among healthcare workers have also been documented in healthcare settings where infection prevention and control measures were not properly implemented. This makes isolation and protective equipment critical when managing confirmed or suspected Andes virus cases.

Explore More At: Hantavirus Is Back in the News: Should You Be Worried?

The Two Major Diseases Hantavirus Causes

Not all hantavirus infections are the same. The virus causes two distinct clinical syndromes depending on which strain infects you and where in the world you are.

Hantavirus Pulmonary Syndrome - HPS

HPS is the dominant form in the Americas, including the United States. It primarily attacks the lungs and cardiovascular system. The Andes virus - responsible for the 2026 outbreak - causes HPS.

According to the CDC, HPS can be deadly. Among patients who develop respiratory symptoms, the case fatality rate is approximately 35 to 50% depending on the strain and the speed and quality of medical care received.

Hemorrhagic Fever with Renal Syndrome - HFRS

HFRS is caused by hantavirus strains dominant in Europe and Asia - including Hantaan, Seoul, Puumala, and Dobrava viruses. It primarily attacks the kidneys. According to WHO, there are an estimated 60,000 to 100,000 cases of HFRS worldwide each year, with China accounting for approximately half.

HFRS has a lower case fatality rate than HPS - between 1% and 15% depending on the strain - but can still cause severe kidney failure, hemorrhage, and death without proper management.

What Happens to Your Body - Stage by Stage

The Incubation Period - Silence Before the Storm

After exposure, hantavirus is invisible. You feel nothing. The incubation period for HPS typically ranges from 1 to 8 weeks - with most cases developing symptoms 2 to 4 weeks after exposure. The Andes virus has an incubation period of up to 42 days - which is why quarantine monitoring for MV Hondius contacts is set at six weeks.

During this silent window, the virus is replicating inside endothelial cells - the cells lining blood vessel walls - quietly preparing to cause the capillary leak syndrome that defines severe hantavirus disease.

Stage 1 - The Prodromal Phase (Days 1 to 7)

The prodromal phase is the initial symptomatic period. It lasts 3 to 10 days and is almost indistinguishable from influenza at this stage.

Common prodromal symptoms include:

• Fever and chills - often sudden and intense
• Deep muscle aches - particularly in large muscle groups including thighs, hips, back, and sometimes shoulders
• Fatigue and headache - severe, out of proportion to other early symptoms
• Nausea, vomiting, and abdominal pain - present in approximately half of all HPS cases
• Diarrhea in some patients

Notably absent from hantavirus prodrome are the runny nose, sore throat, and ear pain typical of common respiratory viruses. This distinction can help alert clinicians - but in practice, diagnosing hantavirus within the first 72 hours is extremely difficult because early symptoms are so nonspecific.

For HFRS specifically, the prodromal phase looks slightly different. Symptoms include sudden fever, headache, lower back pain, nausea, vomiting, and diarrhea - followed by five distinct clinical stages: febrile, hypotensive, oliguric (low urine output), diuretic (high urine output), and recovery.

Stage 2 - The Cardiopulmonary Phase - The Critical Window (Days 4 to 10)

This is the phase that kills. For HPS patients, the transition from prodrome to cardiopulmonary collapse can happen within hours.

Here is what happens biologically: the hantavirus infects and damages endothelial cells lining the pulmonary capillaries. These capillaries become leaky, allowing plasma fluid to pour out of the vascular space directly into the lungs. Pulmonary edema develops rapidly. The lungs fill with fluid. Oxygen delivery to tissues collapses. Cardiac output falls. Blood pressure drops. The patient can progress from walking and talking to requiring mechanical ventilation in under six hours.

According to the CDC:

• Within 24 hours of the cardiopulmonary phase onset, most HPS patients develop hypotension
• Progressive pulmonary edema and hypoxia develop rapidly, usually requiring mechanical ventilation
• Fatal cases involve severe myocardial depression progressing to sinus bradycardia, electromechanical dissociation, or ventricular fibrillation
• Without adequate treatment, most deaths occur within 24 to 48 hours of cardiopulmonary phase onset

Poor prognostic indicators include a plasma lactate above 4.0 mmol/L and a cardiac index below 2.2 L/min/m². When these markers appear, the clinical team is in a race against time.

Stage 3 - The Convalescent Phase - Recovery

Survivors who make it through the cardiopulmonary phase typically recover rapidly. Pulmonary edema clears relatively quickly in survivors. Most recover full pulmonary function within 6 months. Long-term complications are uncommon.

For HFRS, recovery usually takes 3 to 6 weeks but may take up to 6 months. Residual renal dysfunction is uncommon except in the severe Balkan forms. Some HFRS survivors experience chronic kidney impairment.

The critical clinical insight: if a patient survives the first 5 to 7 days of severe disease, the prognosis for full recovery is generally good.

How Is Hantavirus Diagnosed?

Diagnosing hantavirus in the first 72 hours is one of the most challenging aspects of managing this infection. Early symptoms mimic influenza, dengue, leptospirosis, and other febrile illnesses so closely that many clinicians do not consider hantavirus until the patient deteriorates rapidly.

The CDC uses an enzyme-linked immunosorbent assay (ELISA) to detect IgM antibodies and diagnose acute hantavirus infection. This method is used for both HPS and HFRS. PCR testing is also available for direct viral detection - and was the method used to confirm the first positive cases aboard the MV Hondius.

The critical clinical trigger for suspecting hantavirus is this combination: sudden fever, deep muscle aches, and severe shortness of breath - combined with a history of rodent exposure or, in the current outbreak context, contact with a confirmed case or travel on the MV Hondius.

If you have these symptoms after known or possible exposure, see a physician immediately and report the exposure history. Do not wait for symptoms to worsen. The window for effective supportive intervention is narrow.

Treatment - What Doctors Actually Do

This is the question everyone is asking. The honest answer is simultaneously sobering and hopeful.

There Is No Approved Antiviral

There is no specific antiviral treatment for hantavirus in the United States. No WHO or FDA approved vaccine or antiviral therapy currently exists for either HPS or HFRS. This is a critical starting point for understanding why timing and quality of supportive care are so decisive.

Ribavirin - Limited and Strain-Dependent

Ribavirin is an antiviral drug that has been tested in both HPS and HFRS. The results differ significantly by syndrome.

For HFRS: ribavirin given intravenously early in the disease course can decrease illness severity and reduce mortality. Early initiation has been shown to be effective and may prevent the need for dialysis.

For HPS: clinical trials have not demonstrated significant benefit. Ribavirin is not routinely recommended for HPS. Administering ribavirin after the cardiopulmonary phase begins is not effective. Some South American centers continue to use it empirically in early confirmed cases, and for the MV Hondius cluster, ribavirin decisions are being made on a case-by-case basis in consultation with infectious disease specialists.

Supportive Care - The Real Treatment

Supportive care is the cornerstone of hantavirus treatment and must be delivered in an intensive care unit by experienced clinicians. The goal is not to kill the virus - it is to keep the patient alive through the critical phase until the body clears the infection.

For HPS patients, ICU-level supportive care includes:

Respiratory support. Supplemental oxygen is provided initially. As hypoxia worsens, mechanical ventilation is initiated. Ventilator settings must be carefully managed to avoid worsening barotrauma in already-damaged lungs.

ECMO - the most powerful intervention available. Extracorporeal membrane oxygenation (ECMO) is a life support technology that takes over the function of the heart and lungs. In HPS patients showing early signs of decompensation, initiating ECMO is associated with approximately 80% survival - compared to 35 to 50% mortality without it. This is the single most significant advancement in HPS management. The CDC specifically states: "In severe cases, ECMO can significantly improve survival (up to approximately 80%) if started early."

Fluid management - counterintuitive and critical. Unlike bacterial sepsis where aggressive fluid resuscitation is standard, HPS patients have leaky capillaries that are already moving fluid into lung tissue. Pouring in intravenous fluids worsens pulmonary edema and accelerates respiratory failure. Fluid management in HPS requires extreme precision - enough to maintain perfusion pressure, not so much as to flood the lungs further.

Vasopressors. When blood pressure drops during cardiogenic shock, vasopressors such as norepinephrine are used to maintain adequate perfusion of vital organs.

Pain and fever management. Acetaminophen is used for fever and pain control. Aspirin and NSAIDs are avoided because they can worsen platelet function and increase bleeding risk.

For HFRS patients, the ICU focus shifts to kidney support:

Hydration and electrolyte management. Careful IV fluid balance, electrolyte monitoring, and blood pressure control protect the kidneys.

Dialysis. For HFRS patients with severe renal insufficiency, dialysis - including intermittent hemodialysis and hemofiltration - can be lifesaving. The MSD Manual confirms dialysis may be required to correct severe fluid overload and can be life-saving during the oliguric phase.

Platelet transfusion. Acute thrombocytopenia - a dangerous drop in platelets - is managed with platelet transfusions to prevent hemorrhagic complications.

Treatments Under Research

Several experimental approaches are under investigation for hantavirus, though none are currently licensed:

• Favipiravir - a broad-spectrum antiviral with greater efficacy than ribavirin in animal models, now in early human trials
• Lactoferrin - a natural protein with demonstrated ability to prevent viral adhesion to host cells in early-stage infections
• Monoclonal antibodies - targeting hantavirus surface glycoproteins, in early development
• mRNA vaccines - following the COVID-19 vaccine success, researchers are applying similar technology to hantavirus candidates

According to NETEC (National Emerging Special Pathogens Training and Education Center), suspected HPS is a medical emergency. Patients should be in ICU-level settings as early as possible - before diagnosis is confirmed. The window for intervention is brutally narrow.

Survival Rates - The Honest Numbers

With prompt, aggressive supportive care, HPS survival rates have improved to approximately 60 to 70% in specialized centers. The Andes virus in the 2026 MV Hondius outbreak shows a case fatality rate of approximately 38% - potentially elevated by delayed diagnosis in a non-clinical environment and the unusual person-to-person transmission dynamic of a confined ship.

HFRS carries a lower case fatality rate of 1 to 15% depending on the strain. Puumala virus - the most common HFRS strain in Europe - has a fatality rate below 1%. Hantaan virus - common in East Asia - carries a higher fatality rate.

For survivors, the prognosis is generally excellent. Those who survive the first few days of severe disease improve rapidly and recover completely in the majority of cases.

Prevention - What You Can Actually Control

There is no vaccine. There is no proven antiviral for HPS. Prevention is therefore the single most powerful tool available.

Rodent control at home. The CDC states clearly that rodent control is the primary strategy for preventing HPS. Seal holes and gaps in your home and garage. Use traps. Remove food sources that attract rodents. Reduce clutter where rodents nest.

Safe cleaning of contaminated areas. Never dry sweep or vacuum rodent droppings. Open doors and windows to ventilate enclosed spaces for at least 30 minutes before entering. Wear gloves and an N95 respirator mask. Spray droppings with a 10% bleach solution, wait five minutes, then wipe with paper towels and dispose safely.

High-risk occupations. Pest exterminators, farm workers, hikers, and campers in areas where hantavirus is endemic are at highest risk. Always wear appropriate respiratory protection when working in potentially contaminated enclosed spaces.

Andes virus - specific precautions. For the 2026 outbreak context, the ECDC recommends that all people who had close contact with confirmed cases quarantine for up to 42 days and monitor symptoms daily. If fever develops, seek medical attention immediately and disclose the exposure history.

Know the warning signs. Harvard Health advises: if you have been around rodents and develop fever, deep muscle aches, and severe shortness of breath - see a doctor immediately. Tell your doctor about the rodent exposure. Speed of diagnosis and transfer to ICU care are directly correlated with survival.

Supporting Your Immune System - Why It Matters

While hantavirus treatment is purely clinical and hospital-based, a well-functioning immune system is a meaningful background factor in how any serious infection progresses. The same oxidative stress and inflammatory dysregulation that drives poor outcomes in many viral infections also impairs immune response efficiency.

Chronic inflammation, micronutrient deficiencies - particularly vitamin C, vitamin D, and zinc - poor sleep, and a diet high in ultra-processed foods all compromise the immune system's ability to respond effectively to viral threats. These are the daily modifiable factors that determine how resilient your immune defenses are before any pathogen challenge occurs.

For people looking to support their baseline immune resilience through traditional herbal approaches, Naturem's Stamina Capsules combine adaptogenic herbs from Traditional Vietnamese Medicine - including Fructus Lycii, Morinda officinalis, and Eucommia ulmoides - that are traditionally used to support vital energy, physical resilience, and systemic balance.

Find out more about daily foods that silently weaken your immune defenses and how to build a diet that supports your body's frontline defenses in Naturem's complete guide to the anti-inflammatory diet.

Final Takeaway: Prevention First, Fast Care If Exposed

Hantavirus is a serious, potentially fatal infection with no approved cure and no licensed vaccine. If you catch it, your survival depends almost entirely on three things: how quickly you are diagnosed, how rapidly you reach an ICU with ECMO capability, and how aggressively the medical team manages your cardiopulmonary or renal failure.

The 2026 MV Hondius outbreak is a rare and unusual event caused by the Andes strain - the only hantavirus that spreads person-to-person. The risk to the general public remains extremely low, as WHO and CDC have both emphasized clearly and repeatedly.

What you can control is prevention. Rodent control. Safe cleaning practices. Immediate medical attention after potential exposure. And the daily choices that keep your immune system as strong as possible before any illness occurs.